Projects
(Principal Investigator)



Results 1-27 of 27 (Search time: 0.004 seconds).

Start DateTitleP-InvestigatorFunding Organization/經費來源
2019Leukocyte Cell-Derived Chemotaxin 2 in Epithelial Ovarian Cancer Progression- Its Role of Angiogenesis and Immune Suppression Within the Tumor MicroenvironmentLING-HUNG WEIMinistry of Science and Technology
2018Targeting Ovarian Cancer Ascites Spheroids: Elucidating Its Regulation to Unveil New Insights and Targets for Therapeutic ManipulationLING-HUNG WEIMinistry of Science and Technology
2017Targeting Ovarian Cancer Ascites Spheroids: Elucidating Its Regulation to Unveil New Insights and Targets for Therapeutic ManipulationLING-HUNG WEIMinistry of Science and Technology
2016Targeting Ovarian Cancer Ascites Spheroids: Elucidating Its Regulation to Unveil New Insights and Targets for Therapeutic ManipulationLING-HUNG WEIMinistry of Science and Technology
2015Epigenetic Therapy of Gynecologic Cancers---Identify and Elucidate Histone 3 Lysine 9 (H3K9) Methyltransferase G9a as a Molecular TargetLING-HUNG WEIMinistry of Science and Technology
2014Epigenetic Therapy of Gynecologic Cancers: Identify and Elucidate Histone 3 Lysine 9 (H3K9) Methyltransferase G9a as a Molecular TargetLING-HUNG WEIMinistry of Science and Technology
2014Peritoneal Inflammation and Ovarian Cancer Progression: IL-6 Trans Signaling as a Therapeutic TargetLING-HUNG WEINational Institutes of Health (NIH)
2013Epigenetic Therapy of Gynecologic Cancers---Identify and Elucidate Histone 3 Lysine 9 (H3k9) Methyltransferase G9a as a Molecular TargetLING-HUNG WEIScience and Technology Information Center, National Science Council
2013Peritoneal Inflammation and Ovarian Cancer Progression: IL-6 Trans Signaling as a Therapeutic TargetLING-HUNG WEINational Institutes of Health (NIH)
2012Identification and Comprehensive Epigenetic Characterization of Ovarian Carcinogenesis by Using Integrative Genomics Analysis PlatformLING-HUNG WEIScience and Technology Information Center, National Science Council
2012Characterization and Identification Histone Methyltransferase G9a as an Effective Therapeutic Target in Type II Endometrial CancerLING-HUNG WEIScience and Technology Information Center, National Science Council
2012Peritoneal Inflammation and Ovarian Cancer Progression: IL-6 Trans Signaling as a Therapeutic TargetLING-HUNG WEINational Institutes of Health (NIH)
2011Identification and Comprehensive Epigenetic Characterization of Ovarian Carcinogenesis by Using Integrative Genomics Analysis PlatformLING-HUNG WEIScience and Technology Information Center, National Science Council
2011Histone Lysine Methylation Pathway in Ovarian Carcinogenesis - Crosstalk between H3k9 Histone Methyltransferase G9a and MicrornaLING-HUNG WEIScience and Technology Information Center, National Science Council
2011Refining of the IL-6R Inhibitory Peptide by Computational Molecular Modeling and High Throughput ScreeningLING-HUNG WEINational Institutes of Health (NIH)
2010Identification and Comprehensive Epigenetic Characterization of Ovarian Carcinogenesis by Using Integrative Genomics Analysis PlatformLING-HUNG WEIScience and Technology Information Center, National Science Council
2010Refining of IL-6R Inhibitory Peptide by Computational Molecular Modeling and High Throughput ScreeningLING-HUNG WEINational Institutes of Health (NIH)
2009Histone Deacetylases as the Molecular Therapeutic Targets for Overcoming the Acquired Paclitaxel Resistance in Epithelial Ovarian Cancer-Identification, Verification, and Elucidation the Transcriptional and Post-Translational MechanismsLING-HUNG WEIScience and Technology Information Center, National Science Council
2009Refining of the IL-6Ra Inhibitory Peptide by Computational Molecular Modeling and High Throughput ScreeningLING-HUNG WEIHospital and Social Welfare Organizations Administration Commission, MOHW
2008Histone Deacetylases as the Molecular Therapeutic Targets for Overcoming the Acquired Paclitaxel Resistance in Epithelial Ovarian Cancer- Identification, Verification, and Elucidation the Transcriptional and Post-Translational MechanismsLING-HUNG WEIScience and Technology Information Center, National Science Council
2007Epigenetic-Based Therapies for Epithelial Ovarian Cancer---A Strategy to Optimize Conventional ChemotherapyLING-HUNG WEIScience and Technology Information Center, National Science Council
2006The Study of Radiosensitization and Chemosensitization via Blockade of gp-80 Transactivation by a Novel Small Peptide in Human Cervical Cancer Cells (II)LING-HUNG WEIScience and Technology Information Center, National Science Council
2005The Study of Radiosensitization and Chemosensitization via Blockade of gp-80 Transactivation by a Novel Small Peptide in Human Cervical Cancer Cells (I)LING-HUNG WEIScience and Technology Information Center, National Science Council
2005Application of Low Dose Arsenic Trioxide on the Treatment of Solid Tumors-Focusing on the Adjuvant Use as an Antimetastatic Drug and Investigating the Mechanisms of ActionLING-HUNG WEIHospital and Social Welfare Organizations Administration Commission, MOHW
2004An Antitumor Strategy for Cervical and Ovarian Cancers by Using Small Peptide Targeting IL-6R (gp80)LING-HUNG WEIScience and Technology Information Center, National Science Council
2003A Strategy for Antitumor Therapy by Targeting the IL-6R (gp80) Using Phage Display System in Cervical and Ovarian CancerLING-HUNG WEIScience and Technology Information Center, National Science Council
2000Histone Deacetylases as the Molecular Therapeutic Targets for Overcoming the Acquired Paclitaxel Resistance in Epithelial Ovarian Cancer- Identification, Verification, and Elucidation the Transcriptional and Post-Translational MechanismsLING-HUNG WEIScience and Technology Information Center, National Science Council